Analyst initiations: WX, MYGN, CYPB and KNOL
Posted Sep 18th 2007 11:20AM by Eric Buscemi
Filed under: Analyst reports, Electronic Arts (ERTS), Activision Inc (ATVI), Analyst initiations, Delta Air Lines (DAL)
.gif)
MOST NOTEWORTHY: Aerospace stocks, WuXi Pharma, Myriad Genetics, Cypress Bioscience and Knology were today's noteworthy initiations:
- LYON initiated shares of aerospace stocks including Goodrich Corporation (NYSE: GR), TransDigm Group Inc (NYSE: TDG) and Triumph Group Incorporated (NYSE: TGI) with Add ratings and a $74 target, $45 target and $90 target, respectively.
- WuXi Pharmatech (NYSE: WX) was started with a Hold rating and $29 target at Jefferies on valuation. JP Morgan started shares with a Neutral rating and Credit Suisse initiated shares with an Outperform rating.
- Myriad Genetics Inc (NASDAQ: MYGN) was started with a Hold rating and $50 target at Citigroup, as the firm is cautious on the Phase III Flurizan results and does not recommend putting new money here at these levels.
- Citigroup also initiated shares of Cypress Biosciences Inc (NASDAQ: CYPB) with a Buy rating and $22 target as the firm believes Milnacipran has sufficient database for approval and is capable of gaining meaningful market share as firstline therapy.
- Knology Inc (NASDAQ: KNOL) was initiated with a Buy rating and $25 target at BWS Financial, as the firm believes the company's growth potential is greater than other cable companies through a business plan that allows it to have operations in all regions of the U.S.
OTHER INITIATIONS:
Tags: activision, analyst, atvi, cypb, cypress, dal, delta, electronic arts, ElectronicArts, erts, firm, goodrich, gr, initiation, knol, knology, lcapa, liberty media, LibertyMedia, mygn, myriad, northwest airlines, NorthwestAirlines, nwa, tdg, tel, tgi, thq, thqi, transdigm, triumph group, TriumphGroup, tyco, wuxi, wx
Best & Worst in Money 2008: Most shocking financial collapse
Closing Bell: Stocks slump as AMD, AT&T, GM and Merck decline
Global Q&A: A rocky road, but profits ahead
